Literature DB >> 8637251

Infant leukaemia biology, aetiology and treatment.

M F Greaves1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8637251

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  27 in total

1.  Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia.

Authors:  L Sun; N Heerema; L Crotty; X Wu; C Navara; A Vassilev; M Sensel; G H Reaman; F M Uckun
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

2.  Network-based expression analysis reveals key genes related to glucocorticoid resistance in infant acute lymphoblastic leukemia.

Authors:  Zaynab Mousavian; Abbas Nowzari-Dalini; Ronald W Stam; Yasir Rahmatallah; Ali Masoudi-Nejad
Journal:  Cell Oncol (Dordr)       Date:  2016-10-31       Impact factor: 6.730

3.  Leukemia in infants.

Authors:  Saika Somjee; Rupa Sapre; Shaila Shinde; Ashok Kumar; Subodh Dhond; Y Badrinath; Shashikant Mahadik; Anuradha Chougale; Rasheeda Ansari; C N Nair; S H Advani
Journal:  Indian J Pediatr       Date:  2002-03       Impact factor: 1.967

4.  Granulocytic sarcoma in MLL-positive infant acute myelogenous leukemia: fluorescence in situ hybridization study of childhood acute myelogenous leukemia for detecting MLL rearrangement.

Authors:  K U Park; D S Lee; H S Lee; C J Kim; H I Cho
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

5.  Common chromatin structures at breakpoint cluster regions may lead to chromosomal translocations found in chronic and acute leukemias.

Authors:  Reiner Strick; Yanming Zhang; Neelmini Emmanuel; Pamela L Strissel
Journal:  Hum Genet       Date:  2006-03-30       Impact factor: 4.132

6.  Chemical genomic screening identifies LY294002 as a modulator of glucocorticoid resistance in MLL-rearranged infant ALL.

Authors:  J A P Spijkers-Hagelstein; S S Pinhanços; P Schneider; R Pieters; R W Stam
Journal:  Leukemia       Date:  2013-08-20       Impact factor: 11.528

Review 7.  Molecular pathogenesis of MLL-associated leukemias.

Authors:  Mariko Eguchi; Minenori Eguchi-Ishimae; Mel Greaves
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

8.  Maternal vitamin and iron supplementation and risk of infant leukaemia: a report from the Children's Oncology Group.

Authors:  A M Linabery; S E Puumala; J M Hilden; S M Davies; N A Heerema; M A Roesler; J A Ross
Journal:  Br J Cancer       Date:  2010-10-26       Impact factor: 7.640

9.  In vitro cleavage of the MLL gene by topoisomerase II inhibitor (etoposide) in normal cord and peripheral blood mononuclear cells.

Authors:  Eiichi Ishii; Mariko Eguchi; Minenori Eguchi-Ishimae; Nobuyuki Yoshida; Megumi Oda; Masafumi Zaitsu; Ichiro Fujita; Sumio Miyazaki; Yuhei Hamasaki; Shuki Mizutani
Journal:  Int J Hematol       Date:  2002-07       Impact factor: 2.490

10.  Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants.

Authors:  Emma M C Driessen; Eddy H J van Roon; Jill A P Spijkers-Hagelstein; Pauline Schneider; Paola de Lorenzo; Maria Grazia Valsecchi; Rob Pieters; Ronald W Stam
Journal:  Haematologica       Date:  2013-02-12       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.